Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

25 Jun 2024 07:00

RNS Number : 6762T
Anpario PLC
25 June 2024
 
Anpario plc("Anpario", "Group" or the "Company")

 

AGM Statement

 

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today, at which Matthew Robinson, Chairman, will make the following statement:

 

"The Group has delivered a strong sales performance and a corresponding improvement in profit in the first half of the year as the global agriculture market continues to improve and we are confident of achieving market expectations for the full year. There are still challenges to navigate and as highlighted at the time of our 2023 full year results announcement on 20 March 2024, we expected individual territory performance to be variable. In contrast to the strong first half performances last year in the United States and Australia, both territories have experienced weaker trading in the current period. However, all other regions have delivered strong sales growth with notable performances from Asia Pacific, Middle East and Africa and South America, demonstrating the resilience afforded by our geographic diversity.

 

The Group's business development initiatives are centred around expanding in the ruminant and aquaculture sectors as well as working with several partners in pet food where we can offer natural sustainable solutions. Our unique water-soluble phytogenic product Orego-Stim® Forte, for aquatic species, continues to show excellent field trial results, especially for inhibiting the growth of Vibrio species of bacteria in the absence of antibiotics. As such we are experiencing strong interest for this product from across the aquaculture industry.

 

Raw material prices have stabilised and together with increased volumes through our highly automated production facility we are delivering improved gross margins and profitability. Our cash position has improved further since the year end, with a balance of £12.2m as at 31 May 2024, giving us a strong financial position with which to continue to grow the business, both organically and through acquisitions, should the right opportunities arise."

 

The Company's interim results for the six months period ended 30 June 2024 are expected to be announced on 11 September 2024. 

 

 

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLTREISFIS
Date   Source Headline
22nd Jun 202211:24 amRNSAGM Statement
16th Jun 20226:00 pmRNSResult of AGM
16th Jun 20227:00 amRNSAGM Statement
27th May 202212:56 pmRNSHolding(s) in Company
24th May 20221:10 pmRNSHolding(s) in Company
11th May 20227:00 amRNSNotice of AGM
10th May 20223:55 pmRNSHolding(s) in Company
5th May 20223:18 pmRNSHolding(s) in Company
4th May 20221:14 pmRNSTotal Voting Rights
28th Apr 202211:17 amRNSHolding(s) in Company
20th Apr 20221:49 pmRNSHolding(s) in Company
19th Apr 20223:47 pmRNSHolding(s) in Company
8th Apr 20227:00 amRNSDirectorate Change
6th Apr 202210:10 amRNSHolding(s) in Company
6th Apr 202210:09 amRNSTotal Voting Rights
1st Apr 20223:41 pmRNSHolding(s) in Company
25th Mar 202210:40 amRNSHolding(s) in Company
24th Mar 202212:57 pmRNSGrant of share awards
22nd Mar 20225:08 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results
8th Mar 20222:35 pmRNSBlock listing Interim Review
8th Mar 20222:34 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSFull Year Trading Statement
3rd Dec 20217:00 amRNSUK patent granted for Orego-stim
18th Nov 20211:17 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSNew Commitment to Sustainable Operations
3rd Nov 202112:04 pmRNSTotal Voting Rights
1st Nov 202110:03 amRNSHolding(s) in Company
26th Oct 20214:28 pmRNSHolding(s) in Company
12th Oct 20217:20 amRNSDirector/PDMR Shareholding
15th Sep 202111:51 amRNSHalf-year Report - Replacement
15th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20219:52 amRNSTotal Voting Rights
20th Jul 20219:42 amRNSBlock listing Interim Review
9th Jul 20212:16 pmRNSAnpario receives “Community Business Hero Award"
17th Jun 20211:24 pmRNSResult of AGM
17th Jun 20217:00 amRNSAGM Statement
7th Jun 20213:58 pmRNSDirector/PDMR Shareholding
24th May 20219:48 amRNSHolding(s) in Company
18th May 20217:00 amRNSNotice of AGM
4th May 20214:16 pmRNSDirector/PDMR Shareholding
4th May 20214:10 pmRNSTotal Voting Rights
28th Apr 20214:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20214:05 pmRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSBoard update
13th Apr 20219:17 amRNSHolding(s) in Company
13th Apr 20219:17 amRNSHolding(s) in Company
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding
30th Mar 20213:39 pmRNSDirector/PDMR Shareholding
17th Mar 20217:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.